Benutzer: Gast  Login
Titel:

RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV.

Dokumenttyp:
Article; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
Autor(en):
Lorenzen, Sylvie; Biederstädt, Alexander; Ronellenfitsch, Ulrich; Reißfelder, Christoph; Mönig, Stefan; Wenz, Frederik; Pauligk, Claudia; Walker, Martin; Al-Batran, Salah-Eddin; Haller, Bernhard; Hofheinz, Ralf-Dieter
Abstract:
BACKGROUND: Despite obvious advances over the last decades, locally advanced adenocarcinomas of the gastroesophageal junction (GEJ) still carry a dismal prognosis with overall 5-year survival rates of less than 50% even when using modern optimized treatment protocols such as perioperative chemotherapy based on the FLOT regimen or radiochemotherapy. Therefore the question remains whether neoadjuvant chemotherapy or neoadjuvant radiochemotherapy is eliciting the best results in patients with GEJ c...     »
Zeitschriftentitel:
BMC Cancer
Jahr:
2020
Band / Volume:
20
Heft / Issue:
1
Volltext / DOI:
doi:10.1186/s12885-020-07388-x
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/32933498
TUM Einrichtung:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie); Institut für Medizinische Statistik und Epidemiologie
 BibTeX